Sakar Healthcare Limited (SAKAR.NS)
INR 242.24
(-3.49%)
INR 242.24
(-3.49%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 549.55 Million INR | -44.05% |
| 2022 | 982.28 Million INR | 15.55% |
| 2021 | 850.07 Million INR | 121.08% |
| 2020 | 384.5 Million INR | 208.29% |
| 2019 | 124.72 Million INR | 113.1% |
| 2018 | 58.52 Million INR | -40.54% |
| 2017 | 98.42 Million INR | -38.12% |
| 2016 | 159.06 Million INR | 3.15% |
| 2015 | 154.21 Million INR | -17.89% |
| 2014 | 187.81 Million INR | 6.68% |
| 2013 | 176.06 Million INR | -11.11% |
| 2012 | 198.06 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 497.14 Million INR | 0.0% |
| 2023 FY | 549.55 Million INR | -44.05% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 549.55 Million INR | 0.0% |
| 2023 Q2 | 628.35 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 862.82 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 982.28 Million INR | 15.55% |
| 2022 Q4 | 982.28 Million INR | 0.0% |
| 2021 FY | 850.07 Million INR | 121.08% |
| 2021 Q4 | 850.07 Million INR | 0.0% |
| 2021 Q2 | 534.39 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 384.5 Million INR | 208.29% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 384.5 Million INR | 0.0% |
| 2020 Q2 | 292.87 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 Q4 | 124.72 Million INR | 0.0% |
| 2019 FY | 124.72 Million INR | 113.1% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 93.57 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 84.56 Million INR | 0.0% |
| 2018 Q4 | 58.52 Million INR | 0.0% |
| 2018 FY | 58.52 Million INR | -40.54% |
| 2017 FY | 98.42 Million INR | -38.12% |
| 2017 Q4 | 98.42 Million INR | 0.0% |
| 2017 Q2 | 154.34 Million INR | 0.0% |
| 2016 Q4 | 159.06 Million INR | 0.0% |
| 2016 FY | 159.06 Million INR | 3.15% |
| 2015 Q1 | 174.94 Million INR | -6.85% |
| 2015 Q4 | 154.21 Million INR | -0.0% |
| 2015 Q2 | 174.94 Million INR | 0.0% |
| 2015 FY | 154.21 Million INR | -17.89% |
| 2015 Q3 | 154.21 Million INR | -11.85% |
| 2014 FY | 187.81 Million INR | 6.68% |
| 2014 Q4 | 187.81 Million INR | 0.0% |
| 2013 FY | 176.06 Million INR | -11.11% |
| 2012 FY | 198.06 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aarti Drugs Limited | 2.75 Billion INR | 80.04% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -137287.5% |
| Albert David Limited | 6.01 Million INR | -9034.807% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | 12.603% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -411.057% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| FDC Limited | 2.46 Million INR | -22185.077% |
| Gufic Biosciences Limited | 1.53 Billion INR | 64.306% |
| Hikal Limited | 4.22 Billion INR | 87.004% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -392.314% |
| Ind-Swift Limited | 10.09 Billion INR | 94.556% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 98.265% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -311.522% |
| Medico Remedies Limited | 8.67 Million INR | -6237.062% |
| Morepen Laboratories Limited | 33.64 Million INR | -1533.621% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 60.833% |
| Orchid Pharma Limited | 1.2 Billion INR | 54.368% |
| Procter & Gamble Health Limited | 68.8 Million INR | -698.765% |
| RPG Life Sciences Limited | -30.3 Million INR | 1913.696% |
| Alembic Limited | 73.9 Million INR | -643.64% |
| Alkem Laboratories Limited | 400 Million INR | -37.388% |
| Bajaj HealthCare Limited | 650.34 Million INR | 15.499% |
| Brooks Laboratories Limited | 3.56 Million INR | -15315.147% |
| Eris Lifesciences Limited | 6.54 Billion INR | 91.604% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -272.299% |
| Sigachi Industries Limited | 265.79 Million INR | -106.755% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | 53.206% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -4031.955% |
| Innova Captab Limited | 2.1 Billion INR | 73.896% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -158.787% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -627.207% |
| Themis Medicare Limited | 267.74 Million INR | -105.255% |
| Unichem Laboratories Limited | 382.22 Million INR | -43.778% |
| Vaishali Pharma Limited | 35.98 Million INR | -1427.249% |
| Venus Remedies Limited | 386.8 Million INR | -42.076% |
| Wanbury Limited | 820 Million INR | 32.982% |
| Windlas Biotech Limited | 20.18 Million INR | -2623.241% |
| ZIM Laboratories Limited | 356 Million INR | -54.365% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lupin Limited | 1.55 Billion INR | 64.609% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 97.426% |
| Divi's Laboratories Limited | 20 Million INR | -2647.75% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -1874.242% |
| Mankind Pharma Limited | 325.81 Million INR | -68.669% |
| Sequent Scientific Limited | 1.42 Billion INR | 61.494% |
| Laurus Labs Limited | 7.98 Billion INR | 93.115% |
| Neuland Laboratories Limited | 449.2 Million INR | -22.338% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -132.466% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 63.772% |
| Zydus Lifesciences Limited | 251 Million INR | -118.944% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -3834.35% |
| Wockhardt Limited | 8.91 Billion INR | 93.832% |
| Bal Pharma Limited | 363.82 Million INR | -51.048% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 90.826% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -54.402% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -5873.37% |
| Shilpa Medicare Limited | 5.6 Billion INR | 90.189% |
| Valiant Laboratories Limited | 750.89 Million INR | 26.814% |
| Ajanta Pharma Limited | 235.2 Million INR | -133.652% |
| Hester Biosciences Limited | 1.81 Billion INR | 69.767% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -1604.36% |
| Granules India Limited | 689.71 Million INR | 20.322% |
| Medicamen Biotech Limited | 12.55 Million INR | -4277.141% |
| Ipca Laboratories Limited | 5.8 Billion INR | 90.532% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 45182.034% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.897% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 96.574% |
| NATCO Pharma Limited | 53 Million INR | -936.887% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 70.052% |
| Strides Pharma Science Limited | 6.71 Billion INR | 91.816% |
| Indoco Remedies Limited | 3.51 Billion INR | 84.376% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -415.525% |